patent/PL-407282-A1

Predicate	Object
assignee	http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7560661b745dc00780e49a0e8077b0d9
classificationIPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-198 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-375 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-752
filingDate	2014-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor	http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bf58b52162a1c424f710c4be37589a9d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_023bef299754f98b6b295061bc74f32e
publicationDate	2015-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	PL-407282-A1
titleOfInvention	Pharmaceutical composition
abstract	The composition contains colostrum in an amount of 40 to 70 wt.%, Lysine in an amount of 10 to 30 wt. lemon balm leaf extract in an amount of 5 to 15% by weight, grapefruit seed extract in an amount of 3 to 10% by weight, zinc in an amount of 0.2 to 1.5% by weight, vitamin C in an amount of 1 up to 5 wt. and at least one vitamin B in an amount from 0.05 to 0.5 wt. The composition is intended for people exposed to or attacked by the herpes virus, especially herpes labialis (HSV1).
priorityDate	2014-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23994 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458437694

Total number of triples: 18.